Serum CA125 and NSE: Biomarkers of disease severity in patients with silicosis

Clinica Chimica Acta

Volumn 433, Issue , 2014, Pages 123-127

  Fang, Shen Cun ^a   Zhang, Hai Tao ^a   Wang, Cai Ying ^a   Zhang, Ying Ming ^a  

^a NANJING CHEST HOSPITAL   (China)

Author keywords

CA125; NSE; Silicosis; Tumor marker; Whole lung lavage

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CA 19-9 ANTIGEN; CARBOHYDRATE ANTIGEN; CARBOHYDRATE ANTIGEN 125; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; CA 125 ANTIGEN; ENOLASE;

ADULT; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG FUNCTION TEST; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SILICOSIS; AGED; BLOOD; CASE CONTROL STUDY; MIDDLE AGED;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CA-125 ANTIGEN; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; SILICOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84897086612     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.03.005     Document Type: Article

References (18)

1. Leung C.C., Yu I.T., Chen W. Silicosis. Lancet 2012, 379:2008-2018.
2. Brown T. Silica exposure, smoking, silicosis and lung cancer - complex interactions. Occup Med (Lond) 2009, 59:89-95.
3. Erren T.C., Glende C.B., Morfeld P., Piekarski C. Is exposure to silica associated with lung cancer in the absence of silicosis? A meta-analytical approach to an important public health question. Int Arch Occup Environ Health 2009, 82:997-1004.
4. Bergamaschi S., Morato E., Bazzo M., et al. Tumor markers are elevated in patients with rheumatoid arthritis and do not indicate presence of cancer. Int J Rheum Dis 2012, 15:179-182.
5. Bulut I., Arbak P., Coskun A., et al. Comparison of serum CA 19.9, CA 125 and CEA levels with severity of chronic obstructive pulmonary disease. Med Princ Pract 2009, 18:289-293.
6. Fang S.C., Lu K.H., Wang C.Y., Zhang H.T., Zhang Y.M. Elevated tumor markers in patients with pulmonary alveolar proteinosis. Clin Chem Lab Med 2013, 1-6.
7. Totani Y., Demura Y., Ameshima S., Ishizaki T., Miyamori I. Silicosis characterized by increasing serum CA 19-9 in parallel with progression of lung fibrosis. Nihon Kokyuki Gakkai Zasshi 2000, 38:137-142.
8. Mukae H., Ishimoto H., Yanagi S., et al. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis. Respir Med 2007, 101:715-721.
9. Wilt J.L., Banks D.E., Weissman D.N., et al. Reduction of lung dust burden in pneumoconiosis by whole-lung lavage. J Occup Environ Med 1996, 38:619-624.
10. Deniz O., Gumus S., Ors F., et al. Serum lactate dehydrogenase levels significantly correlate with radiological extent of disease and spirometric values in patients with silicosis due to denim sandblasting. Clin Chem Lab Med 2012, 50:483-488.
11. Rosenman K.D., Reilly M.J., Gardiner J. Results of spirometry among individuals in a silicosis registry. J Occup Environ Med 2010, 52:1173-1178.
12. Sahin F., Yildiz P. Serum CA-125: biomarker of pulmonary tuberculosis activity and evaluation of response to treatment. Clin Invest Med 2012, 35:E223.
13. Fang S.C., Lu K.H., Wang C.Y., Zhang H.T., Zhang Y.M. Elevated tumor markers in patients with pulmonary alveolar proteinosis. Clin Chem Lab Med 2013, 51:1493-1498.
14. Rusanov V., Kramer M.R., Raviv Y., Medalion B., Guber A., Shitrit D. The significance of elevated tumor markers among patients with idiopathic pulmonary fibrosis before and after lung transplantation. Chest 2012, 141:1047-1054.
15. Shimizu Y., Hamada T., Tanaka Y., Sasaki A., Nemoto T. Colocalization of CA19-9 and KL-6 to epithelial cells in dilated bronchioles in a patient with idiopathic pulmonary fibrosis complicated by diffuse alveolar damage. Respirology 2002, 7:281-284.
16. Kodama T., Satoh H., Ishikawa H., Ohtsuka M. Serum levels of CA19-9 in patients with nonmalignant respiratory diseases. J Clin Lab Anal 2007, 21:103-106.
17. Elizegi E., Pino I., Vicent S., Blanco D., Saffiotti U., Montuenga L.M. Hyperplasia of alveolar neuroendocrine cells in rat lung carcinogenesis by silica with selective expression of proadrenomedullin-derived peptides and amidating enzymes. Lab Invest 2001, 81:1627-1638.
18. Fang C.S., Wang Y.C., Zhang T.H., et al. Clinical significance of serum lipids in idiopathic pulmonary alveolar proteinosis. Lipids Health Dis 2012, 11:12.